IRCT20120922010901N7招募中3 期
The effect of metformin on the early outcome of patients undergoing ovarian cancer chemotherapy
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- Female
入选标准
- •Confirmed ovarian epithelial cancer with pathology report
- •Serum cancer antigen 125 level above 35 mg/dl
- •Laparotomy and surgical tumor staging candidate
排除标准
- •Gastrointestinal disorders
- •Kidney failure
- •Metformin intolerance
- •Having other cancers in addition to ovarian epithelial cancer
- •Previous history of chemotherapy
- •Serum cancer antigen 125 level equal and lower than 35 mg/dl
研究者
相似试验
已完成
2 期
Evaluation of metformin effect on progression of autosomal dominant polycystic kidney disease; a clinical trialAutosomal Dominant Polycystic Kidney Disease.Polycystic kidney, adult typeIRCT2012102111194N1Vice-chancellor for research,Tehran University of Medical Science30
已完成
不适用
Effect of Metformin (Drug)in Patients With Cryptogenic Cirrhosis (Liver Disease) With DiabetesCTRI/2018/03/012814Institute of liver and Biliary Sciences86
招募中
2 期
Therapeutic effect of metformin in rectal cancerRectal cancer.Malignant neoplasm of rectumIRCT20190726044335N1Shiraz University of Medical Sciences90
已完成
不适用
timing of metformi administration and exerciseNutritional, Metabolic, EndocrinePACTR202203690920424Faculty of medicine of sousse15
进行中（未招募）
1 期
Study to evaluate the effect of metformin in the prevention of hyperglycemiain HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients treatedwith alpelisib plus endocrine therapy. The Metallica study.Study to evaluate the effect of metformin in the prevention of hyperglycemiain HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients treatedwith alpelisib plus endocrine therapy. The Metallica study.CTIS2024-511295-33-00Medica Scientia Innovation Research S.L.88